The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Open accessAbstract
Medicinal plants have historically proven their value as a source of molecules with therapeutic potential, and nowadays still represent an important pool for the identification of novel drug leads. In the past decades, pharmaceutical industry focused mainly on libraries of synthetic compounds as drug discovery source. They are comparably easy to produce and resupply, and demonstrate good compatibility with established high throughput screening (HTS) platforms. However, at the same time there has been a declining trend in the number of new drugs reaching the market, raising renewed scientific interest in drug discovery from natural sources, despite of its known challenges. In this survey, a brief outline of historical development is provided together with a comprehensive overview of used approaches and recent developments relevant to plant-derived natural product drug discovery. Associated challenges and major strengths of natural product-based drug discovery are critically discussed. A snapshot of the advanced plant-derived natural products that are currently in actively recruiting clinical trials is also presented. Importantly, the transition of a natural compound from a "screening hit" through a "drug lead" to a "marketed drug" is associated with increasingly challenging demands for compound amount, which often cannot be met by re-isolation from the respective plant sources. In this regard, existing alternatives for resupply are also discussed, including different biotechnology approaches and total organic synthesis. While the intrinsic complexity of natural product-based drug discovery necessitates highly integrated interdisciplinary approaches, the reviewed scientific developments, recent technological advances, and research trends clearly indicate that natural products will be among the most important sources of new drugs also in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This diversity of plants and secondary metabolites present in these plants indicates tremendous possibilities for drug discovery and development [3,4].”
From Yellow Himalayan Raspberry (Rubus ellipticus Sm.): Ethnomedicinal, Nutraceutical, and Pharmacological Aspects (2023) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green Chemistry: Theory and Practice
Anastas, P. T., & Warner, J. C. (1998) · Medical Entomology and Zoology · Cited by 8,599
Extinction risk from climate change
Thomas, C. D., Cameron, A., Green, R. E., Bakkenes, M., Beaumont, L. J., Collingham, Y. C., Erasmus, B. F. N., de Siqueira, M. F., Grainger, A., Hannah, L., et al. (2004) · Nature · doi:10.1038/nature02121 · Cited by 7,695
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Smith, C. A., Want, E. J., O'Maille, G., Abagyan, R., & Siuzdak, G. (2006) · Analytical Chemistry · doi:10.1021/ac051437y · Cited by 5,262
Green Chemistry: Principles and Practice
Anastas, P., & Eghbali, N. (2010) · Chem. Soc. Rev. · doi:10.1039/b918763b · Cited by 5,256
The Atom Economy—A Search for Synthetic Efficiency
Trost, B. (1991) · Science · doi:10.1126/science.1962206 · Cited by 4,798
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Next-generation DNA sequencing
Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Pluskal, T., Castillo, S., Villar-Briones, A., & Orešič, M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-395 · Cited by 3,845
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Influence of abiotic stress signals on secondary metabolites in plants
Akula, R., & Ravishankar, G. A. (2011) · Plant Signaling & Behavior · doi:10.4161/psb.6.11.17613 · Cited by 2,516
Qinghaosu (Artemisinin): an Antimalarial Drug from China
Klayman, D. L. (1985) · Science · doi:10.1126/science.3887571 · Cited by 2,186
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
High-level semi-synthetic production of the potent antimalarial artemisinin
Paddon, C. J., Westfall, P. J., Pitera, D. J., Benjamin, K., Fisher, K., McPhee, D., Leavell, M. D., Tai, A., Main, A., Eng, D., et al. (2013) · Nature · doi:10.1038/nature12051 · Cited by 2,060
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
Li, J. W.-H., & Vederas, J. C. (2009) · Science · doi:10.1126/science.1168243 · Cited by 2,052
The value of plants used in traditional medicine for drug discovery.
Fabricant, D. S., & Farnsworth, N. R. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109s169 · Cited by 2,038
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Elicitor signal transduction leading to production of plant secondary metabolites
Zhao, J., Davis, L. C., & Verpoorte, R. (2005) · Biotechnology Advances · doi:10.1016/j.biotechadv.2005.01.003 · Cited by 1,948
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
The E Factor: fifteen years on
Sheldon, R. A. (2007) · Green Chemistry · doi:10.1039/b713736m · Cited by 1,680
Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli
Ajikumar, P. K., Xiao, W.-H., Tyo, K. E. J., Wang, Y., Simeon, F., Leonard, E., Mucha, O., Phon, T. H., Pfeifer, B., & Stephanopoulos, G. (2010) · Science · doi:10.1126/science.1191652 · Cited by 1,677
Antioxidant activity of food constituents: an overview
Gülçin, İ. (2012) · Archives of Toxicology · doi:10.1007/s00204-011-0774-2 · Cited by 1,663
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
Cos, P., Vlietinck, A. J., Berghe, D. V., & Maes, L. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.003 · Cited by 1,603
Plant cell cultures: Chemical factories of secondary metabolites
Ramachandra Rao, S., & Ravishankar, G. A. (2002) · Biotechnology Advances · doi:10.1016/s0734-9750(02)00007-1 · Cited by 1,480
Drug Discovery and Evaluation: Pharmacological Assays
(2014) · Springer eBooks · doi:10.1007/978-3-642-27728-3 · Cited by 1,409
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Farnsworth, N., Akerele, O., & Bingel, A. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90016-x · Cited by 1,362
Swine as Models in Biomedical Research and Toxicology Testing
Swindle, M. M., Makin, A., Herron, A. J., Clubb, F. J., & Frazier, K. S. (2012) · Veterinary Pathology · doi:10.1177/0300985811402846 · Cited by 1,357
Synergy research: approaching a new generation of phytopharmaceuticals.
Wagner, H., & Ulrich-Merzenich, G. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.12.018 · Cited by 1,296
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Nicolaou, K. C., Yang, Z., Liu, J. J., Ueno, H., Nantermet, P. G., Guy, R. K., Claiborne, C. F., Renaud, J., Couladouros, E. A., Paulvannan, K., et al. (1994) · Nature · doi:10.1038/367630a0 · Cited by 1,096
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Antioxidant assays for plant and food components
Moon, J.-K., & Shibamoto, T. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803537k · Cited by 958 · cited 2×
“, the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay), have been reviewed elsewhere (Gulcin, 2012; Moon and Shibamoto, 2009) and will not be discussed in detail here.”
MethodQinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
Measuring the metabolome: current analytical technologies
Dunn, W. B., Bailey, N. J. C., & Johnson, H. E. (2005) · The Analyst · doi:10.1039/b418288j · Cited by 924
Langcake, P., & Pryce, R. J. (1976) · Physiological Plant Pathology · doi:10.1016/0048-4059(76)90077-1 · Cited by 912
Metrics to ‘green’ chemistry—which are the best?
Constable, D. J. C., Curzons, A. D., & Cunningham, V. L. (2002) · Green Chem. · doi:10.1039/b206169b · Cited by 910
Trends in the exploitation of novel drug targets
Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Innovations and Green Chemistry
Horváth, I. T., & Anastas, P. T. (2007) · Chemical Reviews · doi:10.1021/cr078380v · Cited by 742
Murthy, H. N., Lee, E.-J., & Paek, K.-Y. (2014) · Plant Cell, Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-014-0467-7 · Cited by 679
Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development
Paddon, C. J., & Keasling, J. D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3240 · Cited by 675
Targeted Genome Editing Across Species Using ZFNs and TALENs
Wood, A. J., Lo, T.-W., Zeitler, B., Pickle, C. S., Ralston, E. J., Lee, A. H., Amora, R., Miller, J. C., Leung, E., Meng, X., et al. (2011) · Science · doi:10.1126/science.1207773 · Cited by 663
Flow chemistry syntheses of natural products
Pastre, J. C., Browne, D. L., & Ley, S. V. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60246j · Cited by 658
Heritable gene targeting in zebrafish using customized TALENs
Huang, P., Xiao, A., Zhou, M., Zhu, Z., Lin, S., & Zhang, B. (2011) · Nature Biotechnology · doi:10.1038/nbt.1939 · Cited by 657
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
Corson, T. W., & Crews, C. M. (2007) · Cell · doi:10.1016/j.cell.2007.08.021 · Cited by 654
The logic of chemical synthesis
Huynh-Dinh, T. (1996) · Biochimie · doi:10.1016/0300-9084(96)89514-9 · Cited by 650
Current approaches and challenges for the metabolite profiling of complex natural extracts
Wolfender, J.-L., Marti, G., Thomas, A., & Bertrand, S. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.10.091 · Cited by 635
Cultivation of medicinal and aromatic plants for specialty industrial materials
Lubbe, A., & Verpoorte, R. (2011) · Industrial Crops and Products · doi:10.1016/j.indcrop.2011.01.019 · Cited by 621
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Curzons, A. D., Mortimer, D. N., Constable, D. J. C., & Cunningham, V. L. (2001) · Green Chemistry · doi:10.1039/b007871i · Cited by 599
The pharmaceutical industry and natural products: historical status and new trends
David, B., Wolfender, J.-L., & Dias, D. A. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-014-9367-z · Cited by 579
The Logic of Chemical Synthesis
Corey, E. J., & Cheng, X. (2011) · Medical Entomology and Zoology · Cited by 574
The Renaissance of Natural Products as Drug Candidates
Paterson, I., & Anderson, E. A. (2005) · Science · doi:10.1126/science.1116364 · Cited by 559
Highly efficient, practical approach to natural taxol
Denis, J. N., Greene, A. E., Guenard, D., Gueritte-Voegelein, F., Mangatal, L., & Potier, P. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00225a063 · Cited by 558
Bringing medicinal plants into cultivation: opportunities and challenges for biotechnology
Canter, P. H., Thomas, H., & Ernst, E. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.02.002 · Cited by 548
S., P. (2011) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.81895 · Cited by 541
LXIII.—A synthesis of tropinone
Robinson, R. (1917) · J. Chem. Soc., Trans. · doi:10.1039/ct9171100762 · Cited by 532
Bohlmann, J., & Keeling, C. I. (2008) · The Plant Journal · doi:10.1111/j.1365-313x.2008.03449.x · Cited by 530
(2007) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · Cited by 522
Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation
Kingston, D. G. I. (2011) · Journal of Natural Products · doi:10.1021/np100550t · Cited by 516
Continuous‐Flow Synthesis of the Anti‐Malaria Drug Artemisinin
Lévesque, F., & Seeberger, P. H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107446 · Cited by 516
The seco-iridoid pathway from Catharanthus roseus
Miettinen, K., Dong, L., Navrot, N., Schneider, T., Burlat, V., Pollier, J., Woittiez, L., van der Krol, S., Lugan, R., Ilc, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms4606 · Cited by 508
Stuart, G. A., & Smith, F. P. (1911) · American Presbyterian Mission Press eBooks · doi:10.5962/bhl.title.25114 · Cited by 505
Probing the links between in vitro potency, ADMET and physicochemical parameters
Gleeson, M. P., Hersey, A., Montanari, D., & Overington, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3367 · Cited by 503
Methods for isolation of marine-derived endophytic fungi and their bioactive secondary products
Kjer, J., Debbab, A., Aly, A. H., & Proksch, P. (2010) · Nature Protocols · doi:10.1038/nprot.2009.233 · Cited by 492
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Indigenous Use and Ethnopharmacology of Medicinal Plants in Far-West Nepal
Kunwar, R. M., Uprety, Y., Burlakoti, C., Chowdhary, C. L., & Bussmann, R. W. (2009) · Ethnobotany Research and Applications · doi:10.17348/era.7.0.5-28 · Cited by 471
Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack
Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208749 · Cited by 466
Comprehensive Natural Products II
(2010) · Elsevier eBooks · doi:10.1016/c2009-1-28362-6 · Cited by 454
Taxol and taxotere: discovery, chemistry, and structure-activity relationships
Guenard, D., Gueritte-Voegelein, F., & Potier, P. (1993) · Accounts of Chemical Research · doi:10.1021/ar00028a005 · Cited by 444
Medical Botany: Plants Affecting Man's Health
Lewis, W. H., & Elvin-Lewis, M. P. F. (1977) · Medical Entomology and Zoology · Cited by 431
Phenotypic screens as a renewed approach for drug discovery
Zheng, W., Thorne, N., & McKew, J. C. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.001 · Cited by 423
Tomás-Barberán, F. A., García-Villalba, R., González-Sarrías, A., Selma, M. V., & Espín, J. C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5024615 · Cited by 419
Why Drugs Fail - A Study on Side Effects in New Chemical Entities
Schuster, D., Laggner, C., & Langer, T. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774414510 · Cited by 417 · cited 2×
“…proper selection of the initially used pharmacological assay is underlined by the fact that lack of clinical efficacy (indicative for inappropriate pre-clinical models) is among the most important reasons for failure of novel drugs during development (Kola and Landis, 2004; Schuster et al., 2005).”
BackgroundSelf-citationChinese Materia Medica: Chemistry, Pharmacology and Applications
Zhu, Y.-P. (1998) · Medical Entomology and Zoology · Cited by 397
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Verpoorte, R. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01167-7 · Cited by 392
Ron, M., Kajala, K., Pauluzzi, G., Wang, D., Reynoso, M. A., Zumstein, K., Garcha, J., Winte, S., Masson, H., Inagaki, S., et al. (2014) · PLANT PHYSIOLOGY · doi:10.1104/pp.114.239392 · Cited by 389
Strategies for the improvement of secondary metabolite production in plant cell cultures
Dörnenburg, H., & Knorr, D. (1995) · Enzyme and Microbial Technology · doi:10.1016/0141-0229(94)00108-4 · Cited by 385
Bowey, E., Adlercreutz, H., & Rowland, I. (2003) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00324-1 · Cited by 380
Engels, B., Dahm, P., & Jennewein, S. (2008) · Metabolic Engineering · doi:10.1016/j.ymben.2008.03.001 · Cited by 378
Kinase Drug Discovery – What’s Next in the Field?
Cohen, P., & Alessi, D. R. (2013) · ACS Chemical Biology · doi:10.1021/cb300610s · Cited by 377
Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review
Malik, S., Cusidó, R. M., Mirjalili, M. H., Moyano, E., Palazón, J., & Bonfill, M. (2011) · Process Biochemistry · doi:10.1016/j.procbio.2010.09.004 · Cited by 374
Natural product isolation – how to get from biological material to pure compounds
Bucar, F., Wube, A., & Schmid, M. (2013) · Natural Product Reports · doi:10.1039/c3np20106f · Cited by 373
Huffman, M. A. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2003257 · Cited by 369
B. Aggarwal, B., Prasad, S., Reuter, S., Kannappan, R., R. Yadav, V., Park, B., Hye Kim, J., C. Gupta, S., Phromnoi, K., Sundaram, C., et al. (2011) · Current Drug Targets · doi:10.2174/138945011798109464 · Cited by 368
PubChem as a public resource for drug discovery
Li, Q., Cheng, T., Wang, Y., & Bryant, S. H. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.10.003 · Cited by 365
Hairy root type plant in vitro systems as sources of bioactive substances
Georgiev, M. I., Pavlov, A. I., & Bley, T. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0856-5 · Cited by 362
Wilson, S. A., & Roberts, S. C. (2012) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2011.00664.x · Cited by 358
In vitro manipulation and propagation of medicinal plants
Rout, G. R., Samantaray, S., & Das, P. (2000) · Biotechnology Advances · doi:10.1016/s0734-9750(99)00026-9 · Cited by 358
Chemography: The Art of Navigating in Chemical Space
Oprea, T. I., & Gottfries, J. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc0000388 · Cited by 353
14-Step Synthesis of (+)-Ingenol from (+)-3-Carene
Jørgensen, L., McKerrall, S. J., Kuttruff, C. A., Ungeheuer, F., Felding, J., & Baran, P. S. (2013) · Science · doi:10.1126/science.1241606 · Cited by 347
Creek, D. J., Jankevics, A., Breitling, R., Watson, D. G., Barrett, M. P., & Burgess, K. E. V. (2011) · Analytical Chemistry · doi:10.1021/ac2021823 · Cited by 344
Recent ecological responses to climate change support predictions of high extinction risk
Maclean, I. M. D., & Wilson, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017352108 · Cited by 339
Mining the Biodiversity of Plants: A Revolution in the Making
De Luca, V., Salim, V., Atsumi, S. M., & Yu, F. (2012) · Science · doi:10.1126/science.1217410 · Cited by 337
Ketting, R. F. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.01.012 · Cited by 337
Natural products and combinatorial chemistry: back to the future
Ortholand, J.-Y., & Ganesan, A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.011 · Cited by 336
Tan, G. T., Pezzuto, J. M., Kinghorn, A. D., & Hughes, S. H. (1991) · Journal of Natural Products · doi:10.1021/np50073a012 · Cited by 331
Baxendale, I. R., Deeley, J., Griffiths-Jones, C. M., Ley, S. V., Saaby, S., & Tranmer, G. K. (2006) · Chemical Communications · doi:10.1039/b600382f · Cited by 331
Horváth6, I. T., & Anastas, P. T. (2007) · Chemical Reviews · doi:10.1021/cr0783784 · Cited by 323
Centenary Lecture. Biomimetic chemistry
Breslow, R. (1972) · Chemical Society Reviews · doi:10.1039/cs9720100553 · Cited by 315
A natural history of botanical therapeutics
Schmidt, B., Ribnicky, D. M., Poulev, A., Logendra, S., Cefalu, W. T., & Raskin, I. (2008) · Metabolism · doi:10.1016/j.metabol.2008.03.001 · Cited by 309
Preclinical experimental models of drug metabolism and disposition in drug discovery and development
Zhang, D., Luo, G., Ding, X., & Lu, C. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.10.004 · Cited by 309
Cragg, G. M., Schepartz, S. A., Suffness, M., & Grever, M. R. (1993) · Journal of Natural Products · doi:10.1021/np50100a001 · Cited by 308
Diversity of the biosynthesis of the isoprene units
Kuzuyama, T., & Seto, H. (2003) · Natural Product Reports · doi:10.1039/b109860h · Cited by 303
Sneader, W. (2005) · Cited by 302
Ethnopharmacology in drug discovery: an analysis of its role and potential contribution
Heinrich, M., & Gibbons, S. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775712 · Cited by 300
Metabolic engineering of flavonoids in plants and microorganisms
Wang, Y., Chen, S., & Yu, O. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3449-2 · Cited by 299
Natural Products as a Foundation for Drug Discovery
Beutler, J. A. (2009) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0911s46 · Cited by 296
Pharmaceutically Active Natural Product Synthesis and Supply via Plant Cell Culture Technology
Kolewe, M. E., Gaurav, V., & Roberts, S. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp7001494 · Cited by 294
Lee, M.-L., & Schneider, G. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc000097l · Cited by 293
Schippmann, U., Leaman, D., & Cunningham, A. B. (2007) · Wageningen UR Frontis Series · doi:10.1007/1-4020-5449-1_6 · Cited by 293
Brusotti, G., Cesari, I., Dentamaro, A., Caccialanza, G., & Massolini, G. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.03.007 · Cited by 292
The Relevance of Higher Plants in Lead Compound Discovery Programs
Kinghorn, A. D., Pan, L., Fletcher, J. N., & Chai, H. (2011) · Journal of Natural Products · doi:10.1021/np200391c · Cited by 282
Leonti, M. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.01.017 · Cited by 281
Advances in plant molecular farming
Obembe, O. O., Popoola, J. O., Leelavathi, S., & Reddy, S. V. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.11.004 · Cited by 276
Pharmacognosy in the New Millennium: Leadfinding and Biotechnology
Verpoorte, R. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773931 · Cited by 274
Fürst, R., & Zündorf, I. (2014) · Mediators of Inflammation · doi:10.1155/2014/146832 · Cited by 269
Phylogenies reveal predictive power of traditional medicine in bioprospecting
Saslis-Lagoudakis, C. H., Savolainen, V., Williamson, E. M., Forest, F., Wagstaff, S. J., Baral, S. R., Watson, M. F., Pendry, C. A., & Hawkins, J. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202242109 · Cited by 267
C. elegans in high-throughput drug discovery
O'Reilly, L. P., Luke, C. J., Perlmutter, D. H., Silverman, G. A., & Pak, S. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.001 · Cited by 267
Eldridge, G. R., Vervoort, H. C., Lee, C. M., Cremin, P. A., Williams, C. T., Hart, S. M., Goering, M. G., O'Neil-Johnso, M., & Zeng, L. (2002) · Analytical Chemistry · doi:10.1021/ac025534s · Cited by 258
Mans, D. R. A., Rocha, A. B., & Schwartsmann, G. (2000) · The Oncologist · doi:10.1634/theoncologist.5-3-185 · Cited by 254
Extraction of Plant Secondary Metabolites
Jones, W. P., & Kinghorn, A. D. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-624-1_13 · Cited by 254
Isolation of Artemisinin (Qinghaosu) from Artemisia annua Growing in the United States
Klayman, D. L., Lin, A. J., Acton, N., Scovill, J. P., Hoch, J. M., Milhous, W. K., Theoharides, A. D., & Dobek, A. S. (1984) · Journal of Natural Products · doi:10.1021/np50034a027 · Cited by 251 · cited 2×
“…treatment of Alzheimer's disease and was initially discovered in Galanthus nivalis L. (Mashkovsky and Kruglikova-Lvova, 1951), and the important antimalarial and potential anti-cancer agent artemisinin originally derived from the traditional Chinese herb Artemisia annua L. (Klayman et al., 1984).”
Background21st Century natural product research and drug development and traditional medicines
Ngo, L. T., Okogun, J. I., & Folk, W. R. (2013) · Natural Product Reports · doi:10.1039/c3np20120a · Cited by 248
A flow-microreactor approach to protecting-group-free synthesis using organolithium compounds
Kim, H., Nagaki, A., & Yoshida, J.-I. (2011) · Nature Communications · doi:10.1038/ncomms1264 · Cited by 246
Robertson, A. L., Holmes, G. R., Bojarczuk, A. N., Burgon, J., Loynes, C. A., Chimen, M., Sawtell, A. K., Hamza, B., Willson, J., Walmsley, S. R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007672 · Cited by 245
Plant Metabolomics: From Holistic Data to Relevant Biomarkers
Wolfender, J.-L., Rudaz, S., Hae Choi, Y., & Kyong Kim, H. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713805288932 · Cited by 242
Ethnopharmacology and drug discovery
Patwardhan, B. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.06.006 · Cited by 240
Maes, J., Verlooy, L., Buenafe, O. E., de Witte, P. A. M., Esguerra, C. V., & Crawford, A. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043850 · Cited by 238
ADME/PK as part of a rational approach to drug discovery
Eddershaw, P. J., Beresford, A. P., & Bayliss, M. K. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01540-3 · Cited by 237
Harrison, M. M., Jenkins, B. V., O’Connor-Giles, K. M., & Wildonger, J. (2014) · Genes & Development · doi:10.1101/gad.248252.114 · Cited by 226
Advancing secondary metabolite biosynthesis in yeast with synthetic biology tools
Siddiqui, M. S., Thodey, K., Trenchard, I., & Smolke, C. D. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2011.00774.x · Cited by 226
Chen, X., Zhou, L., Tian, K., Kumar, A., Singh, S., Prior, B. A., & Wang, Z. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.02.009 · Cited by 225
Metabolic engineering of microorganisms for the synthesis of plant natural products
Marienhagen, J., & Bott, M. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.06.001 · Cited by 224
Cragg, G. M. L. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<315::aid-med3>3.0.co;2-w · Cited by 223
Metabolic engineering for plant natural product biosynthesis in microbes
Chemler, J. A., & Koffas, M. A. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.011 · Cited by 222
Heebner, G., & Gwynne, P. H. (2002) · Science · Cited by 220
Unification of Reaction Metrics for Green Chemistry: Applications to Reaction Analysis
Andraos, J. (2005) · Organic Process Research & Development · doi:10.1021/op049803n · Cited by 217
Genetically transformed roots: from plant disease to biotechnological resource
Georgiev, M. I., Agostini, E., Ludwig-Müller, J., & Xu, J. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.07.001 · Cited by 215
The multiplicity of hairy root cultures: Prolific possibilities
Ono, N. N., & Tian, L. (2011) · Plant Science · doi:10.1016/j.plantsci.2010.11.012 · Cited by 215
Botanical Drugs, Synergy, and Network Pharmacology: Forth and Back to Intelligent Mixtures
Gertsch, J. (2011) · Planta Medica · doi:10.1055/s-0030-1270904 · Cited by 212
ChemGPS-NP: Tuned for Navigation in Biologically Relevant Chemical Space
Larsson, J., Gottfries, J., Muresan, S., & Backlund, A. (2007) · Journal of Natural Products · doi:10.1021/np070002y · Cited by 209
Paclitaxel: biosynthesis, production and future prospects
Howat, S., Park, B., Oh, I. S., Jin, Y.-W., Lee, E.-K., & Loake, G. J. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.02.010 · Cited by 208
On Being Green: Can Flow Chemistry Help?
Ley, S. V. (2012) · The Chemical Record · doi:10.1002/tcr.201100041 · Cited by 207
Lange, B. M., & Ahkami, A. (2013) · Plant Biotechnology Journal · doi:10.1111/pbi.12022 · Cited by 206
(1986) · DigitalGeorgetown (Georgetown University Library) · Cited by 205
Role of biotechnology in medicinal plants
Tripathi, L., & Tripathi, J. N. (2005) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v2i2.14607 · Cited by 202
Fürstner, A. (2011) · Chemical Communications · doi:10.1039/c1cc10464k · Cited by 199
Alkaloids as drug leads – A predictive structural and biodiversity-based analysis
Amirkia, V., & Heinrich, M. (2014) · Phytochemistry Letters · doi:10.1016/j.phytol.2014.06.015 · Cited by 197
Cultured cambial meristematic cells as a source of plant natural products
Lee, E.-K., Jin, Y.-W., Park, J. H., Yoo, Y. M., Hong, S. M., Amir, R., Yan, Z., Kwon, E., Elfick, A., Tomlinson, S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1693 · Cited by 196
Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
Lee, J. A., Uhlik, M. T., Moxham, C. M., Tomandl, D., & Sall, D. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201649s · Cited by 192
Review: Drug Therapy in Chinese Traditional Medicine
Cheng, J. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009198 · Cited by 190
Mabona, U., Viljoen, A., Shikanga, E., Marston, A., & Van Vuuren, S. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.03.056 · Cited by 190
Recent advances in the heterologous expression of microbial natural product biosynthetic pathways
Ongley, S. E., Bian, X., Neilan, B. A., & Müller, R. (2013) · Natural Product Reports · doi:10.1039/c3np70034h · Cited by 186
Micropropagation: A Tool for the Production of High Quality Plant-based Medicines
Debnath, M., Malik, C. P., & Bisen, P. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106775789638 · Cited by 184
Culturversuche mit isolierten Pflanzenzellen
Haberlandt, G. (2003) · Plant Tissue Culture · doi:10.1007/978-3-7091-6040-4_1 · Cited by 182
Wenzel, S. C., & Müller, R. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.10.001 · Cited by 181
Lipid Data Analyzer: unattended identification and quantitation of lipids in LC-MS data
Hartler, J., Trötzmüller, M., Chitraju, C., Spener, F., Köfeler, H. C., & Thallinger, G. G. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btq699 · Cited by 181
Metabolomics for bioactivity assessment of natural products
Yuliana, N. D., Khatib, A., Choi, Y. H., & Verpoorte, R. (2011) · Phytotherapy Research · doi:10.1002/ptr.3258 · Cited by 180
Drug-like Properties: Guiding Principles for the Design of Natural Product Libraries
Camp, D., Davis, R. A., Campitelli, M., Ebdon, J., & Quinn, R. J. (2012) · Journal of Natural Products · doi:10.1021/np200687v · Cited by 176
Ebada, S. S., Edrada, R. A., Lin, W., & Proksch, P. (2008) · Nature Protocols · doi:10.1038/nprot.2008.182 · Cited by 171
Natural product synthesis in the age of scalability
Kuttruff, C. A., Eastgate, M. D., & Baran, P. S. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70090a · Cited by 171
Cannon, J. S., & Overman, L. E. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107385 · Cited by 169
Monitoring Keap1–Nrf2 interactions in single live cells
Baird, L., Swift, S., Llères, D., & Dinkova-Kostova, A. T. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.03.004 · Cited by 167
Synthese von Haschisch‐Inhaltsstoffen. 4. Mitteilung
Petrzilka, T., Haefliger, W., & Sikemeier, C. (1969) · Helvetica Chimica Acta · doi:10.1002/hlca.19690520427 · Cited by 167
Evaluating costs for the in vitro propagation and preservation of endangered plants
Pence, V. C. (2011) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-010-9323-6 · Cited by 165
Bench to batch: advances in plant cell culture for producing useful products
Weathers, P. J., Towler, M. J., & Xu, J. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2354-4 · Cited by 165
Virtual screening for the discovery of bioactive natural products
Rollinger, J. M., Stuppner, H., & Langer, T. (2008) · Natural Compounds as Drugs Volume I · doi:10.1007/978-3-7643-8117-2_6 · Cited by 163
Self-citationTarget deconvolution techniques in modern phenotypic profiling
Lee, J., & Bogyo, M. S. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.12.022 · Cited by 159
Saslis‐Lagoudakis, C. H., Klitgaard, B. B., Forest, F., Francis, L., Savolainen, V., Williamson, E. M., & Hawkins, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022275 · Cited by 158
Where is the hope for drug discovery? Let history tell the future
De, K., Li, X., & Zhang, H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.002 · Cited by 158
Junio, H. A., Sy‐Cordero, A. A., Ettefagh, K. A., Burns, J. T., Micko, K. T., Graf, T. N., Richter, S. J., Cannon, R. E., Oberlies, N. H., & Cech, N. B. (2011) · Journal of Natural Products · doi:10.1021/np200336g · Cited by 154
Generation of the potent anti-malarial drug artemisinin in tobacco
Farhi, M., Marhevka, E., Ben‐Ari, J., Algamas‐Dimantov, A., Liang, Z., Zeevi, V., Edelbaum, O., Spitzer‐Rimon, B., Abeliovich, H., Schwartz, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.2054 · Cited by 153
A Concise Synthesis of (+)-Artemisinin
Zhu, C., & Cook, S. P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3061479 · Cited by 153
Sertuerner (1817) · Annalen der Physik · doi:10.1002/andp.18170550104 · Cited by 148
Besumbes, Ó., Sauret-Gueto, S., Phillips, M. A., Imperial, S., Rodríguez-Concepción, M., & Boronat, A. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20237 · Cited by 148
Varietal differences in distribution of quercetin and kaempferol in onion (Allium cepa L.) tissue
Bilyk, A., Cooper, P. L., & Sapers, G. M. (1984) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00122a024 · Cited by 147
Taxanes: perspectives for biotechnological production
Frense, D. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0711-0 · Cited by 147
Atkinson, C., Humbert, O., Lampe, J. W., & Berman, S. H. (2004) · Journal of Nutrition · doi:10.1093/jn/134.3.596 · Cited by 147
Elucidation of (−)-epicatechin metabolites after ingestion of chocolate by healthy humans
Actis‐Goretta, L., Lévèques, A., Giuffrida, F., Romanov‐Michailidis, F., Viton, F., Barron, D., Dueñas, M., González‐Manzano, S., Santos‐Buelga, C., Williamson, G., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.023 · Cited by 146
Production of aromatic compounds in bacteria
Gosset, G. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.09.012 · Cited by 146
Matching the power of high throughput screening to the chemical diversity of natural products
Henrich, C. J., & Beutler, J. A. (2013) · Natural Product Reports · doi:10.1039/c3np70052f · Cited by 144
Rollinger, J. M., Schuster, D., Danzl, B., Schwaiger, S., Markt, P., Schmidtke, M., Gertsch, J., Raduner, S., Wolber, G., Langer, T., et al. (2008) · Planta Medica · doi:10.1055/s-0028-1088397 · Cited by 144
Self-citationA High-Throughput Cell-Based Assay for Inhibitors of ABCG2 Activity
Henrich, C. J., Bokesch, H. R., Dean, M. C., Bates, S. E., Robey, R. W., Goncharova, E. I., Wilson, J. A., & McMahon, J. B. (2006) · SLAS DISCOVERY · doi:10.1177/1087057105284576 · Cited by 142
Development of a Concise Synthesis of (+)-Ingenol
McKerrall, S. J., Jørgensen, L., Kuttruff, C. A., Ungeheuer, F., & Baran, P. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja501881p · Cited by 141
153. Phenol oxidation and biosynthesis. Part V. The synthesis of galanthamine
Barton, D. H. R., & KIRBY, G. W. (1962) · Journal of the Chemical Society (Resumed) · doi:10.1039/jr9620000806 · Cited by 140
Honokiol: A non-adipogenic PPARγ agonist from nature
Atanasov, A. G., Wang, J. N., Gu, S. P., Bu, J., Kramer, M. P., Baumgartner, L., Fakhrudin, N., Ladurner, A., Malainer, C., Vuorinen, A., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.021 · Cited by 137
Self-citation
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
Self-citationTechniques for extraction and isolation of natural products: A comprehensive review
Zhang, Q.-W., Lin, L.-G., & Ye, W.-C. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0177-x · Cited by 2,321
The Essential Medicinal Chemistry of Curcumin
Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00975 · Cited by 1,956
Cannabis sativa: The Plant of the Thousand and One Molecules
Andre, C. M., Hausman, J.-F., & Guerriero, G. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00019 · Cited by 1,544
“Continuously discovering new prototypes of drugs is of tremendous importance to meet tomorrow’s challenges in terms of public health (Atanasov et al., 2015).”
Background
Metadata
- Authors
- Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., Rollinger, J. M., Schuster, D., Breuss, J. M., Bochkov, V., Mihovilovic, M. D., Kopp, B., Bauer, R., Dirsch, V. M., & Stuppner, H.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 33
- Issue
- 8
- Pages
- 1582-1614
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W1487878063
- Cited by
- 2,904
- References
- 362
- FWCI
- 53.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.